Mounjaro or Wegovy for beginners: a first-timer's guide

Deciding between Mounjaro or Wegovy as your first weight-loss injection is the single choice that shapes everything that follows — your likely results, your side-effect experience, and roughly what you’ll pay each month. Both are once-weekly jabs, both are prescription-only, and both work by quietening appetite. But they are not the same medicine, and for a first-timer the sensible route is to understand the trade-off rather than pick on the name you’ve heard most.

This guide treats it as a decision, not a sales pitch: what each drug is, how they differ, what beginners worry about, and a simple if-this-then-that framework to land on one.

Mounjaro or Wegovy: the one-line difference

Wegovy is semaglutide, a GLP-1 receptor agonist. It mimics one gut hormone that tells your brain you’re full, so you eat less without white-knuckling it. It’s the most established dedicated weight-loss jab in the UK and the one most people have heard of.

Mounjaro is tirzepatide, a dual hormone jab — it acts on two receptors (GIP and GLP-1) at once. That second mechanism is thought to be why, on average, it produces more weight loss than GLP-1-only medicines. It’s newer to the weight-loss conversation but already the option with the largest average results among current UK choices.

So the headline trade-off for a beginner is straightforward: Mounjaro tends to deliver more weight loss; Wegovy has the longer track record and a unique heart-health credential. Everything below is detail on top of that.

How the two compare, side by side

Here’s the practical comparison most first-timers actually need. Prices shown are The Weight Clinic’s starter-dose figures from our price data (checked 4 July 2026); every provider prices doses differently, so treat these as a realistic example rather than the only number.

Prices: The Weight Clinic starter doses, GLP Finder price data, last checked 4 July 2026. Confirm the current figure on the provider’s own site.

Two things beginners often miss from a table like this. First, Wegovy’s starter dose is cheaper because it’s a lower strength — but the price climbs as you titrate up, so don’t judge the whole journey on month one. Second, the weight-loss percentages are trial averages, not promises; real results vary with dose, diet, activity and how long you stay on treatment.

What beginners actually worry about

Side effects

Both medicines share the same common side effects — nausea, constipation or looser stools, and feeling full quickly — and both are started low and increased slowly precisely to soften that. Wegovy’s titration runs over roughly 16 weeks; Mounjaro also steps up gradually, at least four weeks per dose. Because Mounjaro can go to a higher effective dose, some people find its later steps more noticeable, but this is very individual. The honest answer: neither is guaranteed to be gentler for you personally.

Injecting for the first time

Both are once-weekly injections under the skin of the tummy, thigh or upper arm, on the same day each week, with or without food. Mounjaro uses a KwikPen; Wegovy a pre-filled pen. If needle anxiety is your sticking point, know that both use very fine needles and most people describe the first jab as an anticlimax.

Cost over time

Starter prices are only the first rung. As you titrate up, the monthly cost rises for both. When you compare providers on the GLP Finder price table, look at the dose you expect to settle on, not just the introductory month — that’s the number you’ll live with.

An if-this-then-that framework for choosing

Run yourself through these in order. The first one that fits gives you a strong steer to take to a prescriber.

1. If maximum weight loss is your top priority → lean Mounjaro. It has the largest average results of the current UK options.
2. If you have established heart disease → Wegovy is the only one of the two proven to cut heart attack and stroke risk (the SELECT trial), so raise it specifically with your prescriber.
3. If you want the most established, most-used option and that reassurance matters to you → lean Wegovy.
4. If the cheapest possible first month is decisive → Wegovy’s lower starter strength usually wins early, but re-check at your maintenance dose.
5. If you’re genuinely torn → let eligibility decide. A prescriber may rule one in or out based on your health history, which settles it for you.

Whichever way you lean, the choice isn’t final in the way it feels. People do move between these medicines — our guide on switching between GLP-1 medications covers how that works if your first pick doesn’t suit you.

Before you decide anything: are you eligible?

Both medicines are prescription-only and typically prescribed for a BMI of 30 or over, or 27+ with a weight-related condition. If you’re near the lower end of that range, read your options at a BMI of 27–30 before you get attached to a specific drug — eligibility can shape the choice more than preference does. And if you’re at the very start of the process, our five-question decision guide is the fastest way to see where you stand.

For a broader head-to-head across every option rather than just these two, which GLP-1 is right for me zooms out. And you can always start from the GLP Finder homepage and work through the self-check.

FAQ